Fresenius, which is headquartered in Waltham, MA, currently operates manufacturing and production facilities in Walnut Creek and Pittsburg, CA, and employees in these facilities will relocate to the Concord building following the two phases of large-scale redevelopment. The new site will serve in the same capacity.

“We are excited and pleased to have Fresenius Medical Care North America relocate to Concord,” said John Montagh, economic development manager for the City of Concord, in a prepared statement. “The City worked closely with Harvest Properties to provide the needed entitlements to attract Fresenius to Concord Fresenius will bolster the City’s growing medical/life science sector joining other companies such as Cerus Corp., Elite Biomedical, John Muir Core Labs and Microbiology & Quality Associates, who recently relocated to Concord from Berkeley.

According to Harvest Properties’ founder and managing partner John Winther, “Landing a highly credible tenant such as Fresenius prior to closing on the building sale and structuring a long-term, attractive lease creates tremendous value and reduces risk for Harvest, its investment partners, the City of Concord, as well as Fresenius. It’s a win for all involved.”

The investment broker team included Breck Lutz and Jack Lewis of Cornish & Carey, while the leasing brokers were Andy Majewski and Carter Corbitt of CBRE.

As GlobeSt.com reported last week, Harvest will oversee management of Treat Towers, a class-A, LEED-EB Gold-certified office complex in Walnut Creek, which MetLife recently acquired from an Equity Office Properties joint venture. Lutz and Knute Bucklew will assume leasing responsibilities for the project.